Injectable Fluocinolone Implant for the Management of Cystoid Macular Edema in Coats' Disease

A six-year-old boy with history of Coats' disease and cystoid macular edema (CME) was treated with a combination of peripheral retinal laser, anti-vascular endothelial grown factor injections, and short-acting injectable steroids to control his disease process. Given the excellent response to s...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 55(2024), 11 vom: 26. Nov., Seite 679-681
1. Verfasser: Patel, Kishan G (VerfasserIn)
Weitere Verfasser: Abbey, Ashkan M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Case Reports Journal Article Drug Implants Fluocinolone Acetonide 0CD5FD6S2M Glucocorticoids
LEADER 01000caa a22002652c 4500
001 NLM376210478
003 DE-627
005 20250306124927.0
007 cr uuu---uuuuu
008 240813s2024 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20240621-03  |2 doi 
028 5 2 |a pubmed25n1253.xml 
035 |a (DE-627)NLM376210478 
035 |a (NLM)39133686 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Patel, Kishan G  |e verfasserin  |4 aut 
245 1 0 |a Injectable Fluocinolone Implant for the Management of Cystoid Macular Edema in Coats' Disease 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.11.2024 
500 |a Date Revised 11.11.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a A six-year-old boy with history of Coats' disease and cystoid macular edema (CME) was treated with a combination of peripheral retinal laser, anti-vascular endothelial grown factor injections, and short-acting injectable steroids to control his disease process. Given the excellent response to shorter acting steroids and the need for general anesthesia for each procedure, the patient underwent placement of the injectable fluocinolone acetonide implant 0.18 mg (YUTIQ) with control of his CME at 30 months of follow-up. The authors conclude that a long-acting steroid implant may be beneficial in select patients with Coats' disease. [Ophthalmic Surg Lasers Imaging Retina 2024;55:679-681.] 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 7 |a Drug Implants  |2 NLM 
650 7 |a Fluocinolone Acetonide  |2 NLM 
650 7 |a 0CD5FD6S2M  |2 NLM 
650 7 |a Glucocorticoids  |2 NLM 
700 1 |a Abbey, Ashkan M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 55(2024), 11 vom: 26. Nov., Seite 679-681  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnas 
773 1 8 |g volume:55  |g year:2024  |g number:11  |g day:26  |g month:11  |g pages:679-681 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20240621-03  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
951 |a AR 
952 |d 55  |j 2024  |e 11  |b 26  |c 11  |h 679-681